Dan YY - Search Results

1

Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance.

Lim LG, Aung MO, Seet BL, Tan C, Dan YY, Lee YM, Sutedja DS, Fernandes M, Lee GH, Koay E, Lim SG. Lim LG, et al. Among authors: dan yy. World J Gastroenterol. 2010 Oct 7;16(37):4691-6. doi: 10.3748/wjg.v16.i37.4691. World J Gastroenterol. 2010. PMID: 20872970 Free PMC article.

2

Successful listing of patients for liver transplant was related to participation of referring doctor in the transplant program.

Wai CT, Prabhakaran K, Kaur M, Lee YM, Dan YY, Sutedja DS, Aw MM, Quak SH, Mak K, Isaac J, Lee KH, Lim SG. Wai CT, et al. Among authors: dan yy. Transplant Proc. 2004 Oct;36(8):2230-1. doi: 10.1016/j.transproceed.2004.06.046. Transplant Proc. 2004. PMID: 15561201

3

Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics.

Dan YY, Wai CT, Lee YM, Sutedja DS, Seet BL, Lim SG. Dan YY, et al. World J Gastroenterol. 2005 Jul 28;11(28):4344-50. doi: 10.3748/wjg.v11.i28.4344. World J Gastroenterol. 2005. PMID: 16038032 Free PMC article. Clinical Trial.

4

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.

Dan YY, Wai CT, Yeoh KG, Lim SG. Dan YY, et al. Liver Transpl. 2006 May;12(5):736-46. doi: 10.1002/lt.20685. Liver Transpl. 2006. PMID: 16628682 Free article.

5

A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.

Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM. Lim SG, et al. Among authors: dan yy. Antivir Ther. 2006;11(2):245-53. Antivir Ther. 2006. PMID: 16640105 Clinical Trial.

6

Non-invasive models for predicting histology in patients with chronic hepatitis B.

Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG. Wai CT, et al. Among authors: dan yy. Liver Int. 2006 Aug;26(6):666-72. doi: 10.1111/j.1478-3231.2006.01287.x. Liver Int. 2006. PMID: 16842322

7

MARS: a futile tool in centres without active liver transplant support.

Wai CT, Lim SG, Aung MO, Lee YM, Sutedja DS, Dan YY, Aw MM, Quak SH, Lee MK, Da Costa M, Prahbakaran K, Lee KH. Wai CT, et al. Among authors: dan yy. Liver Int. 2007 Feb;27(1):69-75. doi: 10.1111/j.1478-3231.2006.01388.x. Liver Int. 2007. PMID: 17241383

8

Applicability of cost-effectiveness analysis to management of chronic hepatitis B.

Dan YY, Lim SG. Dan YY, et al. J Gastroenterol Hepatol. 2007 Sep;22(9):1357-9. doi: 10.1111/j.1440-1746.2007.05098.x. J Gastroenterol Hepatol. 2007. PMID: 17716341 No abstract available.

9

The economics of treating chronic hepatitis B in Asia.

Dan YY, Aung MO, Lim SG. Dan YY, et al. Hepatol Int. 2008 Sep;2(3):284-95. doi: 10.1007/s12072-008-9049-2. Epub 2008 May 1. Hepatol Int. 2008. PMID: 19669256 Free PMC article.

10

A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).

Lee YM, Sutedja DS, Wai CT, Dan YY, Aung MO, Zhou L, Cheng CL, Wee A, Lim SG. Lee YM, et al. Among authors: dan yy. Hepatol Int. 2008 Jun;2(2):196-201. doi: 10.1007/s12072-008-9058-1. Epub 2008 Feb 28. Hepatol Int. 2008. PMID: 19669304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters